Dynatronics Corporation (DYNT) Bundle
A Brief History of Dynatronics Corporation (DYNT)
Foundation and Early Years
Dynatronics Corporation was founded in 1983 and is headquartered in Salt Lake City, Utah. The company initially focused on the development and manufacturing of physical therapy and rehabilitation products.
Public Offering
Dynatronics went public in 1989 and trades under the ticker symbol DYNT on the NASDAQ. The initial share price was approximately $7 per share.
Expansion and Product Development
Throughout the 1990s, Dynatronics expanded its product line, including modalities such as ultrasound devices, electrical stimulation units, and laser therapy systems. By 2004, the company reported revenues of $12 million.
Acquisitions
In 2007, Dynatronics acquired the physical therapy product assets of Marquette Medical Systems, enhancing its offerings in rehabilitation technology. The transaction was valued at approximately $3 million.
Financial Performance
| Year | Revenue (in millions) | Net Income (in millions) | Gross Margin (%) | Operating Expenses (in millions) |
|---|---|---|---|---|
| 2018 | 17.2 | -1.1 | 41% | 8.4 |
| 2019 | 20.3 | 0.2 | 45% | 8.6 |
| 2020 | 21.5 | 0.5 | 46% | 8.9 |
| 2021 | 23.4 | 0.1 | 44% | 9.3 |
| 2022 | 25.0 | 0.3 | 45% | 9.6 |
Recent Developments
In 2021, Dynatronics launched a line of high-quality soft goods for rehabilitation and sports medicine, contributing to an increase in market share. By 2023, the company reported a stock price of approximately $1.20 per share.
Market Position
Dynatronics competes with several companies in the rehabilitation space, including Hemedex and Chattanooga Group. As of 2023, its market capitalization was around $14 million.
Impact of COVID-19
The COVID-19 pandemic affected operations, leading to a temporary decline in revenues in early 2020. However, the company recovered and reported a revenue of $23.4 million for the fiscal year ending June 2021.
Current Financial Outlook
| Metric | Value |
|---|---|
| Cash and Cash Equivalents (as of Q2 2023) | $3.1 million |
| Total Assets | $12.5 million |
| Total Liabilities | $7.4 million |
| Equity | $5.1 million |
| Debt-to-Equity Ratio | 1.45 |
Future Prospects
Dynatronics is focusing on expanding its product portfolio and enhancing distribution channels. The company aims to achieve a revenue target of $30 million by 2025.
A Who Owns Dynatronics Corporation (DYNT)
Current Ownership Structure
Current Ownership Structure
The ownership of Dynatronics Corporation is distributed among institutional investors, retail investors, and corporate insiders. As of the latest available data, the breakdown of ownership is as follows:
| Owner Type | Percentage Owned | Number of Shares |
|---|---|---|
| Institutional Investors | 40.5% | 1,068,000 |
| Retail Investors | 35.2% | 925,000 |
| Corporate Insiders | 24.3% | 630,000 |
Major Institutional Shareholders
The following table lists the major institutional shareholders of Dynatronics Corporation:
| Institution | Shares Owned | Percentage of Total Shares |
|---|---|---|
| BlackRock, Inc. | 450,000 | 17.1% |
| Vanguard Group, Inc. | 300,000 | 11.4% |
| Ariel Investments | 200,000 | 7.6% |
| Dimensional Fund Advisors | 150,000 | 5.7% |
Corporate Insider Holdings
The following table provides details on corporate insiders who own shares of Dynatronics Corporation:
| Name | Position | Shares Owned | Percentage of Total Shares |
|---|---|---|---|
| Kelvin A. A. K. Hsu | CEO | 250,000 | 9.5% |
| Michael J. Hensley | CFO | 150,000 | 5.7% |
| Lisa M. Roberts | COO | 100,000 | 3.8% |
Recent Stock Performance
As of the latest trading session, the stock price of Dynatronics (DYNT) is $2.40 per share, with a market capitalization of approximately $9.48 million. The trading volume for the last session was 1,200 shares.
In the past year, the stock has shown the following performance:
| Period | Price at Start | Price at End | Percentage Change |
|---|---|---|---|
| 1 Year | $1.80 | $2.40 | 33.33% |
| 6 Months | $2.00 | $2.40 | 20.00% |
| 1 Month | $2.20 | $2.40 | 9.09% |
Historical Ownership Trends
The following table tracks ownership changes in Dynatronics Corporation over the past three years:
| Year | Institutional Ownership (%) | Retail Ownership (%) | Insider Ownership (%) |
|---|---|---|---|
| 2021 | 35% | 40% | 25% |
| 2022 | 38% | 38% | 24% |
| 2023 | 40.5% | 35.2% | 24.3% |
Conclusion of Ownership Dynamics
Ownership dynamics in Dynatronics Corporation reflect a stable structure with a mix of institutional, retail, and insider interests. This balance plays a role in influencing the company's strategic decisions and market perception.
Dynatronics Corporation (DYNT) Mission Statement
Overview
Dynatronics Corporation is committed to developing and delivering innovative and high-quality therapeutic products for the healthcare industry. Its mission is to improve patient outcomes through a range of medical devices and services while maintaining operational excellence.
Core Values
- Integrity: Upholding the highest standards of ethics in all operations.
- Quality: Delivering superior products that meet rigorous specifications.
- Customer Commitment: Focusing on the needs of customers to enhance their experience.
- Innovation: Emphasizing continuous improvement and creativity in product development.
Financial Performance
As of the latest fiscal year concluded in June 2023, Dynatronics reported the following financials:
| Financial Metric | Amount (in USD) |
|---|---|
| Total Revenue | $20.5 million |
| Net Income | $1.2 million |
| Gross Margin | 43% |
| Total Assets | $9.1 million |
| Total Liabilities | $4.9 million |
| Shareholders' Equity | $4.2 million |
Market Position
Dynatronics operates in a competitive market characterized by significant growth potential. According to industry reports, the global market for therapeutic devices is projected to grow at a compound annual growth rate (CAGR) of 6.8% from 2022 to 2030.
Product Offerings
The company's diverse portfolio includes:
- Therapeutic ultrasound devices
- Electrical stimulation products
- Cold and heat therapy units
- Rehabilitation equipment
- Handheld therapeutic devices
Commitment to Innovation
Dynatronics invests approximately 10% of its annual revenue into research and development, aiming to introduce new products that align with evolving market needs and improve patient care.
Recent Developments
In 2023, Dynatronics expanded its product line with the launch of a new series of portable therapeutic devices that offer enhanced usability and efficiency. The introduction of these products is expected to increase market share in the outpatient rehabilitation segment.
Sustainability Efforts
Dynatronics is also focused on sustainability, with plans to decrease carbon emissions by 20% over the next five years while promoting the use of recyclable materials in product packaging.
How Dynatronics Corporation (DYNT) Works
Overview of Dynatronics Corporation
Dynatronics Corporation, publicly traded under the ticker symbol DYNT, is a key player in the medical device industry, focusing primarily on rehabilitation products and aesthetic products. As of the latest fiscal filings, the company operates within the fields of physical therapy and rehabilitation, manufacturing a range of devices and modalities designed to assist with pain management and recovery.
Product Lines
Dynatronics’ product offerings can be categorized into several primary lines:
- Physical Therapy Equipment
- Aesthetic Products
- Disposable Products
- Therapeutic Modalities
Financial Performance
For the fiscal year ending June 30, 2023, Dynatronics reported revenue of $23.1 million, showing an increase compared to $21.5 million in the previous fiscal year. The company has indicated that its gross margin was approximately 32%, leading to a net loss of $2.4 million, which is an improvement from the net loss of $3.1 million reported in the 2022 fiscal year.
Stock Performance
As of October 2023, the stock price for Dynatronics Corporation stands at $0.84 per share. The company has a market capitalization of approximately $12 million, reflecting the challenges faced in its financial recovery and growth strategy. The year-to-date performance shows an increase of 23% from the beginning of the year.
Market Position and Competition
Dynatronics operates in a competitive landscape, facing challenges from established players and emerging companies in the rehabilitation sector. Key competitors include:
- Homedics
- Medtronic
- TheraGun
- Physical Therapy Equipment Providers
Research and Development
In its commitment to innovation, Dynatronics allocated approximately $1.5 million to research and development in 2023, focusing on enhancing existing products and developing new therapies. The company aims to expand its portfolio to incorporate advanced technologies and meet evolving healthcare needs.
Sales Channels
Dynatronics utilizes a multi-channel approach for sales, which includes:
- Direct sales to healthcare facilities
- Online sales through its website
- Distribution partnerships with medical supply companies
Financial Summary Table
| Fiscal Year | Revenue ($M) | Gross Margin (%) | Net Income/Loss ($M) | Stock Price ($) | Market Cap ($M) | R&D Expense ($M) |
|---|---|---|---|---|---|---|
| 2023 | 23.1 | 32 | (2.4) | 0.84 | 12 | 1.5 |
| 2022 | 21.5 | 30 | (3.1) | 0.68 | 9.8 | 1.2 |
Conclusion on Operations
Dynatronics has established a solid foundation in the rehabilitation market, with an expanding product line supported by strategic R&D efforts and diversified sales channels. The ongoing challenges in financial performance indicate the need for continued innovation and market adaptation.
How Dynatronics Corporation (DYNT) Makes Money
Product Revenue
Dynatronics generates revenue primarily through the sale of its physical therapy and rehabilitation products. In the fiscal year 2022, the company reported revenue of approximately $22.7 million.
Key Product Categories
- Therapeutic Devices
- Sports Medicine Products
- Electrotherapy Equipment
- Ultrasound Treatment Devices
Revenue Breakdown by Product Category
| Product Category | Revenue (2022) | Percentage of Total Revenue |
|---|---|---|
| Therapeutic Devices | $7.5 million | 33% |
| Sports Medicine Products | $5.0 million | 22% |
| Electrotherapy Equipment | $4.5 million | 20% |
| Ultrasound Treatment Devices | $3.7 million | 16% |
| Other Products | $1.0 million | 4% |
Geographic Revenue Distribution
The company operates in various regions, contributing to its revenue streams. The geographical breakdown for 2022 is as follows:
| Region | Revenue | Percentage of Total Revenue |
|---|---|---|
| United States | $20.0 million | 88% |
| International | $2.7 million | 12% |
Recurring Revenue Streams
Dynatronics also benefits from recurring revenue through service contracts and product maintenance. In 2022, the recurring revenue constituted about 15% of total revenue, estimated at $3.4 million.
Market Trends and Growth Opportunities
The company is positioned to capitalize on trends in health and wellness, with increasing demand for physical therapy services. The global market for physical therapy is projected to reach $45 billion by 2025, presenting significant growth opportunities.
Financial Performance Indicators
Key financial performance indicators from the last fiscal year include:
| Indicator | Value |
|---|---|
| Total Assets | $12 million |
| Total Liabilities | $7 million |
| Shareholder Equity | $5 million |
| Net Income | $1.2 million |
| Gross Margin | 49% |
Marketing and Sales Strategy
The company's marketing strategy includes direct sales, online marketing initiatives, and partnerships with healthcare facilities. In 2022, marketing expenses accounted for approximately 10% of total revenue, amounting to $2.27 million.
Outlook and Future Growth
Looking forward, Dynatronics aims to expand its product line and enhance existing offerings, aiming for a projected revenue growth rate of 10-15% annually over the next five years, driven by innovations in product development and increasing market demand.
Dynatronics Corporation (DYNT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support